This inventor holds 2 USPTO granted patents and 9 published patent applications. Top assignees: Domantis Limited, Glaxosmithkline Intellectual Property Development Limited. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 38 
1 out of 242 
Years Active: 2014-2015
Title: Thil Dinuk Batuwangala: Innovator in Biopharmaceuticals
Introduction
Thil Dinuk Batuwangala is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapeutic agents. With a total of 2 patents, his work focuses on improving drug delivery systems and enhancing the efficacy of treatments for various diseases.
Latest Patents
Batuwangala's latest patents include groundbreaking inventions. The first patent, titled "Anti-serum albumin binding variants," relates to improved variants of the anti-serum albumin immunoglobulin single variable domains. This invention also encompasses ligands and drug conjugates that comprise such variants, along with compositions, nucleic acids, vectors, and hosts. The second patent, "Polypeptides, antibody variable domains and antagonists," involves anti-VEGF polypeptides and antibody single variable domains (dAbs) that are resistant to degradation by a protease. These innovations are particularly useful for pulmonary and oral administration, as well as for treating cancer and inflammatory diseases, such as arthritis.
Career Highlights
Throughout his career, Thil Dinuk Batuwangala has worked with notable companies, including GlaxoSmithKline Intellectual Property Development Limited and Domantis Limited. His experience in these organizations has allowed him to refine his expertise in the biopharmaceutical sector and contribute to the advancement of medical science.
Collaborations
Batuwangala has collaborated with several professionals in his field, including Carolyn Enever and Haren Arulanantham. These partnerships have facilitated the exchange of ideas and fostered innovation in his research endeavors.
Conclusion
Thil Dinuk Batuwangala is a distinguished inventor whose work in biopharmaceuticals has the potential to transform treatment methodologies. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile